武汉云克隆科技股份有限公司

衰老关键蛋白3(FBLN3)重组蛋白

Recombinant Fibulin 3 (FBLN3)

EFEMP1; DHRD; DRAD; FBNL; MLVT; MTLV; S1-5; EGF-Containing Fibulin-Like Extracellular Matrix Protein 1; Fibrillin-Like; Extracellular protein S1-5

  • 衰老关键蛋白3(FBLN3)重组蛋白产品包装(模拟)
  • 衰老关键蛋白3(FBLN3)重组蛋白产品包装(模拟)
  • Certificate通过ISO 9001、ISO 13485质量体系认证

序列

用法

PBS或其它。

储存

避免反复冻融。2-8°C不超过一个月，-80°C不超过12个月。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。

相关产品

编号适用物种：Mus musculus (Mouse，小鼠)应用(仅供研究使用，不用于临床诊断！)
RPF422Mu01衰老关键蛋白3(FBLN3)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPF422Mu02衰老关键蛋白3(FBLN3)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAF422Mu01衰老关键蛋白3(FBLN3)多克隆抗体WB; IHC; ICC; IP.
PAF422Mu02衰老关键蛋白3(FBLN3)多克隆抗体WB; IHC; ICC; IP.
SEF422Mu衰老关键蛋白3(FBLN3)检测试剂盒(酶联免疫吸附试验法)Enzyme-linked immunosorbent assay for Antigen Detection.
LMF422Mu衰老关键蛋白3(FBLN3)等多因子检测试剂盒(流式荧光发光法)FLIA Kit for Antigen Detection.

参考文献

杂志参考文献
1Fibulin-3 as a Blood and Effusion Biomarker for Pleural Mesothelioma[PubMed: PMC3761217]
Anticancer Res. YKL-40 and mesothelin in the blood of patients with malignant mesothelioma, lung cancer and asbestosis.[Pubmed: 24324091]
Oncology ReportsRole of fibulin-3 in lung cancer: In vivo and in vitro analyses[Spandidos-publications: Source]
Current Pulmonology ReportsDiscovery of new biomarkers for malignant mesothelioma[Springer:Source]
United States Patent Application 20140378336DIAGNOSIS OF CELL PROLIFERATIVE DISEASES[Freepatentsonline:Source]
Thorax.Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma[Pubmed:Pmc4174124]
Egyptian Journal of Chest Diseases and TuberculosisValue of plasma and pleural effusion fibulin-3 levels in the diagnosis of malignant pleural mesothelioma effusions[Pubmed:23050525]
Radiol OncolFibulin-3 as a biomarker of response to treatment in malignant mesothelioma[PubMed: 26401134]
British Journal of Cancer Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis[PubMed: 26263483]
J Thorac Oncol.Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma.[Pubmed:26903362]
BMJ OpenDiagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational study [pubmed:27884852]
25HMGB1 and its hyperacetylated isoform are sensitive and specific serum biomarkers to detect asbestos exposure and to identify mesothelioma patients[pubmed:26733616]
BMJ JournalsDiagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational …[e013324.abstract]
Anticancer Res.Comparison of the Diagnostic Performance of Fibulin-3 and Mesothelin in Patients with Pleural Effusions from Malignant Mesothelioma.[pubmed:28314308]
Dis Markers.A Novel Panel of Serum Biomarkers for MPM Diagnosis.[pubmed:28348450]
The KneeAssociation of fibulin-3 concentrations with the presence and severity of knee osteoarthritis: A cross-sectional study[pubmed:29195846]
Disease markersPlasma Fibulin-3 as a Potential Biomarker for Patients with Asbestos-Related Diseases in the Han Population[pubmed:29200597]
Molecular Medicine ReportsPlacental protein 14 as a potential biomarker for diagnosis of preterm premature rupture of membranes[Pubmed:29749501]
OncotargetThe matrix protein Fibulin-3 promotes KISS1R induced triple negative breast cancer cell invasion[Pubmed:30046386]
Advances in Clinical and Experimental MedicineFibulin-3 and other cartilage metabolism biomarkers in relationship to calprotectin (MRP8/14) and disease activity in rheumatoid arthritis patients treated with …[68362.pdf]
PLoS OnePrediction of pneumoconiosis by serum and urinary biomarkers in workers exposed to asbestos-contaminated minerals[Pubmed: 30946771]